Product Reports Resources Pricing Login Book a demo

Viz

Health Tech & Medtech · San Francisco, United States · Founded 2016

Viz.ai is a healthcare technology company that has developed an AI-powered platform for intelligent care coordination, focusing on the rapid analysis of medical imaging. Founded in 2016, the company's mission was born from a personal experience of one of its founders and the professional frustration of another. Neurosurgeon Dr. Chris Mansi witnessed a patient's death due to preventable delays in care, which inspired him to find a better system. He teamed up with Dr. David Golan, a machine learning post-doc at Stanford who had personally experienced the challenges of a delayed stroke diagnosis. Together, they aimed to use AI to accelerate diagnosis and treatment for time-sensitive conditions. The company's core offering, the Viz.ai One platform, uses a suite of FDA-cleared AI algorithms to analyze medical images like CT scans, EKGs, and echocardiograms in real-time. This enables the platform to automatically detect suspected diseases, such as strokes, pulmonary embolisms, aortic dissections, and aneurysms, and immediately alert the entire specialized care team via a HIPAA-compliant mobile application. This process dramatically reduces the time to diagnosis and intervention, streamlining communication and care pathways between hospitals and specialists. Viz.ai operates on a subscription-based SaaS model, charging hospitals and health systems an annual fee. This model has proven successful, with the platform adopted by over 1,700 hospitals in the U.S. and Europe. The company also partners with pharmaceutical and medical device companies to help accelerate patient access to new therapies and support clinical trial recruitment. Having achieved a valuation of $1.2 billion in April 2022, Viz.ai has raised significant funding from investors including Tiger Global, Insight Partners, Kleiner Perkins, and GV (formerly Google Ventures). Keywords: care coordination, medical imaging AI, stroke detection, disease detection, clinical workflow, health-tech, medical diagnostics, AI algorithms, pulmonary embolism, aortic dissection, neurovascular, cardiovascular, intelligent care, real-time alerts, HIPAA-compliant communication, hospital SaaS, clinical decision support, medical technology, healthcare AI

Valuation $1–2.5B
Revenue $50–100M
Headcount 100–500
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Viz and the history behind them.

Investors

20 investors on Viz's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 7 investors entered at this stage
Series B+ 10 investors entered at this stage
Scale Venture Partners
Insight Partners
SOSA Ventures
Tiger Global
Scale Ventures
Susa Ventures
Sozo Ventures
CIBC Innovation Banking
Bristol-Myers Squibb
Hakluyt Capital

Global footprint

Where Viz has talent and traffic

Workforce by country
8 countries with
team presence
🇺🇸 United States52.3%
🇮🇱 Israel45%
🇿🇦 South Africa0.4%
🇵🇰 Pakistan0.4%
🇮🇹 Italy0.4%
Top 5 of 8 shown
Web traffic by country
63K monthly visits
across markets
🇺🇸 United States56.5%
🇦🇺 Australia6.2%
🇮🇳 India5.2%
🇨🇦 Canada4.6%
🇮🇱 Israel3.3%
Top 5 markets shown

Talent graph

The shape of Viz's talent

Dealroom maps Viz's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 standout operatorsDealroom-flagged across the org
5 AI specialistsincl. 3 core researchers
324 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Viz's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$14M patent portfolio · 6 active families

Estimated portfolio value
$14M
1.1% of valuation · 4.3× larger than top peer MindMaze ($3M)
6 active patent families
Where Viz innovates ClientComputer-aidedComputing systemsData packInformation transfer

Where Viz concentrates vs peers

Each axis is a top-10 topic across Viz and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Viz

An AI-synthesized read of the highest-engagement posts about Viz on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Viz on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.